Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia

Anders Castor, Lars Nilsson, Ingbritt Åstrand‐Grundström, +13

Nature Medicine

Hematological MalignancyDistinct PatternsMedicineStem Cell MobilizationMixed-phenotype Acute Leukemia +8

Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study

Andrea Biondi, Martin Schrappe, Paola De Lorenzo, +13

The Lancet Oncology

Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia

Henrik Lilljebjörn, Rasmus Henningsson, Axel Hyrenius‐Wittsten, +16

Nature Communications

The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia

Kajsa Paulsson, Henrik Lilljebjörn, Andrea Biloglav, +9

Nature Genetics

Genomic LandscapeGenetic DisorderGeneticsGenome AnalysisDisease Gene Identification +4

High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle

Alex J. Tipping, Cristina Pina, Anders Castor, +6

Blood

Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial

Andrea Biondi, Virginie Gandemer, Paola De Lorenzo, +17

The Lancet Haematology

Hematological MalignancyOncologySingle-arm Clinical TrialPediatric HematologyMixed-phenotype Acute Leukemia +5

Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: Multi‐institutional collaborative study

B‐M Frost, Staffan Eksborg, Olle Björk, +5

Medical and Pediatric Oncology

Proteogenomics and Hi-C reveal transcriptional dysregulation in high hyperdiploid childhood acute lymphoblastic leukemia

Minjun Yang, Mattias Vesterlund, Ioannis Siavelis, +12

Nature Communications

Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies

Giovanni Cazzaniga, Paola De Lorenzo, Julia Alten, +22

Haematologica

Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2

Miranda Buitenhuis, Hanneke W. M. van Deutekom, Liesbeth P. Verhagen, +5

Blood